They are saying that the high mortality rates affect only the 2024 fish so far and things are better with the 2025 cohort. I don't have too much trust in that, but that indeed may be an interesting turnaround story if true. As mentioned above the company has switched to a new diet and that might be the cause of the problems, so it is possible that the root cause will be found and resolved in time.
However, in my opinion it is way too risky to invest at this stage. I am keeping CSS on my watchlist to see if they are able to get through 2024 and show an improvement in 2025.
Good luck to all and DYOR.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.28M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CSS (ASX) Chart |
Day chart unavailable